Ginkgo Bioworks Raises $9 Million to Fund Engineering Lab Capabilities


Helping to support engineering microbes it creates to spec for customers across F&F markets including nutrition, health and consumer goods, Ginkgo Bioworks (Boston) has raised $9 million in a Series A round from Felicis Ventures, OS Fund, Data Collective, iGlobe Partners and Vast Ventures.

The biotech company used the new investment round to complete the construction of Bioworks1, which is a 18,000-square-foot, automated organism engineering lab that uses robotics and advanced software. Ginko Bioworks has already begun the design of its Bioworks2 lab, which is slated for construction in early 2017.

More in Home